ESLICARBAZEPINE Drug Patent Profile
✉ Email this page to a colleague
When do Eslicarbazepine patents expire, and when can generic versions of Eslicarbazepine launch?
Eslicarbazepine is a drug marketed by Alkem Labs Ltd, Apotex, Dr Reddys, Hetero Labs Ltd V, Jubilant Generics, Lupin, Sph Zhongxi Pharm, and Torrent. and is included in eight NDAs.
The generic ingredient in ESLICARBAZEPINE is eslicarbazepine acetate. There are twelve drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the eslicarbazepine acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Eslicarbazepine
A generic version of ESLICARBAZEPINE was approved as eslicarbazepine acetate by DR REDDYS on June 29th, 2021.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ESLICARBAZEPINE?
- What are the global sales for ESLICARBAZEPINE?
- What is Average Wholesale Price for ESLICARBAZEPINE?
Summary for ESLICARBAZEPINE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Drug Prices: | Drug price information for ESLICARBAZEPINE |
| DailyMed Link: | ESLICARBAZEPINE at DailyMed |
US Patents and Regulatory Information for ESLICARBAZEPINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Torrent | ESLICARBAZEPINE ACETATE | eslicarbazepine acetate | TABLET;ORAL | 211227-004 | Feb 27, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sph Zhongxi Pharm | ESLICARBAZEPINE ACETATE | eslicarbazepine acetate | TABLET;ORAL | 211247-004 | Nov 3, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Torrent | ESLICARBAZEPINE ACETATE | eslicarbazepine acetate | TABLET;ORAL | 211227-001 | Feb 27, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
